Diagnostic performance of pancreatic fluid aspiration through metagenomic next-generation sequencing for suspected infected pancreatic necrosis
Digestive and Liver Disease · 2025
DOI: 10.1016/j.dld.2024.07.036 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Digestive and Liver Disease, 2025. Verfasst von Pinjie Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: The First Department of Critical Care Medicine, the Second Affiliated Hospital of Anhui Medical University, No. 678, Furong Road, Hefei Economic Deve…. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Pancreatitis, Acute Necrotizing, Metagenomics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
AIMS: This study aimed to evaluate the diagnostic performance of metagenomic next-generation sequencing (mNGS) with pancreatic fluid aspiration for the detection of infected pancreatic necrosis (IPN). METHODS: This retrospective observational study included 66 patients with suspected IPN. The participants simultaneously underwent pancreatic fluid aspiration mNGS, and microbial and blood culture. We compared the diagnostic performance of mNGS with that of culture in the detection of pathogens associated with IPN. RESULTS: Of the 66 patients, 45 (68.2 %) were confirmed to have IPN. Pancreatic fluid aspiration mNGS yielded positive results in 32 of these patients (71.1 %), significantly outperforming microbial culture results (25 patients, 55.6 %; P = 0.039); however, both methods exhibited similar specificity (95.2% vs. 100 %). The results of pancreatic fluid aspiration mNGS and microbial culture matched in 73.3 % (33/45) of patients with IPN. The turnaround time for the mNGS results was significantly shorter than that for the microbial culture method (P < 0.001). In addition, survival analysis demonstrated that a positive mNGS result was not associated with increased mortality (hazard ratio, 0.652; 95 % confidence interval 0.157-2.699, P = 0.555). CONCLUSIONS: Our study highlights the potential of mNGS for diagnosing IPN, with implications for improving patient care by facilitating early and accurate diagnosis, guiding appropriate interventions, and possibly improving patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Department of Critical Care Medicine, the Second Affiliated Hospital of Anhui Medical University, No. 678, Furong Road, Hefei Economic Development Zone, Hefei 230601, Anhui Province, China.
- The First Department of Critical Care Medicine, the Second Affiliated Hospital of Anhui Medical University, No. 678, Furong Road, Hefei Economic Development Zone, Hefei 230601, Anhui Province, China. Electronic address:…
Zitieren
APA
Zhang, P., Lu, Z., Cao, L., Fu, L., Chen, H., & Sun, Y. (2025). Diagnostic performance of pancreatic fluid aspiration through metagenomic next-generation sequencing for suspected infected pancreatic necrosis. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2024.07.036
Vancouver
Zhang P, Lu Z, Cao L, Fu L, Chen H, Sun Y. Diagnostic performance of pancreatic fluid aspiration through metagenomic next-generation sequencing for suspected infected pancreatic necrosis. Digestive and Liver Disease. 2025. doi:10.1016/j.dld.2024.07.036
BibTeX
@article{Zhang2025,
author = {Zhang, Pinjie and Lu, Zhonghua and Cao, Lijun and Fu, Lu and Chen, Hu and Sun, Yun},
title = {Diagnostic performance of pancreatic fluid aspiration through metagenomic next-generation sequencing for suspected infected pancreatic necrosis},
journal = {Digestive and Liver Disease},
year = {2025},
doi = {10.1016/j.dld.2024.07.036}
}
EUVIMED